Results 71 to 80 of about 152,996 (99)
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.
Journal of Crohn's & Colitis, 2016 M. Harris, D. Hartman, Brenda R Lemos, E. Erlich, S. Spence, Sally Kennedy, Theadore Ptak, R. Pruitt, S. Vermeire, B. Fox +9 moresemanticscholar +1 more sourceEffects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.
Journal of Crohn's & Colitis, 2016 D. Hartman, D. Tracey, Brenda R Lemos, E. Erlich, R. Burton, D. Keane, Rutvij Patel, Skaison Kim, K. Bhol, M. Harris, B. Fox +10 moresemanticscholar +1 more sourceAVX-470: A Novel Oral Anti-TNF Antibody with Therapeutic Potential in Inflammatory Bowel Disease
Inflammatory Bowel Diseases, 2013 K. Bhol, D. Tracey, Brenda R Lemos, G. Lyng, E. Erlich, D. Keane, M. S. Quesenberry, A. Holdorf, Lisa D. Schlehuber, Shawn Clark, B. Fox +10 moresemanticscholar +1 more source